FDA clears Hologic bone density system

Hologic has received FDA clearance to incorporate the U.S. National Health and Nutrition Examination Survey (NHANES) Whole Body Reference Data into its Discovery dual x-ray absorptiometry (DXA) systems.

These body composition values treat the management of diseases and conditions when the disease or condition itself, or its treatment, can affect the relative amounts of fat and lean tissue.

The FDA clearance of the Hologic Advanced Body Composition Assessment package opens a new market for the Hologic Discovery whole-body DXA systems, which have primarily been used to measure osteoporosis in women after menopause, according to the Bedford, Mass.-based developer of diagnostic products for women.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.